Dupont Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,530
| Closed | -$78.1K | – | 991 |
|
|
2022
Q4 | $78.1K | Buy |
+1,530
| New | +$78.1K | ﹤0.01% | 997 |
|
|
2022
Q3 | – | Sell |
-2,430
| Closed | -$164K | – | 1622 |
|
|
2022
Q2 | $164K | Buy |
2,430
+915
| +60% | +$61.8K | 0.01% | 1031 |
|
|
2022
Q1 | $167K | Sell |
1,515
-1,978
| -57% | -$218K | 0.01% | 1124 |
|
|
2021
Q4 | $337K | Sell |
3,493
-1,393
| -29% | -$134K | 0.01% | 939 |
|
|
2021
Q3 | $427K | Buy |
+4,886
| New | +$427K | 0.01% | 955 |
|